Publications by authors named "Rebeca Suarez-Fuentetaja"
Background: The inflammatory cascade is the main cause of death in COVID-19 patients. Corticosteroids (CS) and tocilizumab (TCZ) are available to treat this escalation but which patients to administer it remains undefined.
Objective: We aimed to evaluate the efficacy of immunosuppressive/anti-inflammatory therapy in COVID-19, based on the degree of inflammation.
Introduction: The COVID-19 pandemic has brought about a paradigm shift in healthcare.
Objective: To evaluate the utility of a strategy to comprehensively address the pandemic in a health area that covers 42,000 people.
Method: Between March 10 and May 15, 2020, the COVID Unit was created in the corresponding regional hospital, and an independent circuit was established for the diagnosis and management of patients with suspected or confirmed COVID-19; social health centers were monitored with PCR testing.